| Dec'17 | Dec'16 | Dec'15 | Dec'14 | Dec'13 | Dec'12 |
|---|---|---|---|---|---|
Research and development | |||||
2,517 | 8,881 | 7,694 | 4,441 | 732 | 140 |
Pre commercialization | |||||
479 | 1,085 | 829 | 0 | 0 | - |
General and administrative | |||||
2,959 | 5,900 | 6,953 | 2,639 | 416 | 86 |
Total operating expenses | |||||
5,955 | 15,866 | 15,476 | 7,080 | - | - |
Loss from operations | |||||
-5,955 | -15,866 | -15,476 | -7,080 | -1,148 | -226 |
Financial income, net | |||||
38 | 60 | 135 | 58 | 3 | -3 |
Loss before taxes on income | |||||
-5,917 | -15,806 | -15,341 | -7,022 | -1,145 | - |
Taxes on income | |||||
28 | 216 | 24 | 0 | 0 | - |
Net loss | |||||
-5,945 | -16,022 | -15,365 | -7,022 | -1,145 | -229 |
Basic and diluted net loss per share | |||||
-1.79 | -5.03 | -5.40 | - | - | - |
Deemed dividend | |||||
- | - | - | - | 26 | 0 |
Net loss attributable to Ordinary shareholders | |||||
- | - | - | -7,022 | -1,171 | -229 |
Net loss per share attributable to Ordinary shareholders - basic and diluted | |||||
- | - | - | -0.57 | 0.14 | -0.03 |
Weighted average number of Ordinary shares used in computing basic and diluted net loss per share | |||||
3,313 | 3,188 | 2,846 | 12,259 | 8,423 | 7,551 |